Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 212
Phase 32

Trial Status

Completed19

Role Distribution

Principal Investigator19
PI Rate100%

Activity Timeline

Clinical Trials (19)

NCT00000284Phase 2Completed
Role of Metabolites in Nicotine Dependence (1) - 1
Tobacco Use Disorder
Principalinvestigator
NCT00000285Phase 1Completed
Effects of Phenytoin on Cocaine Use in Humans - 2
Cocaine-Related Disorders
Principalinvestigator
NCT00000286Phase 2Completed
Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
Cocaine-Related Disorders
Principalinvestigator
NCT00000287Completed
Relapse Patterns in Female Cocaine Users - 4
Cocaine-Related Disorders
Principalinvestigator
NCT00000288Phase 2Completed
Role of Metabolites in Nicotine Dependence (2) - 5
Tobacco Use Disorder
Principalinvestigator
NCT00000289Phase 2Completed
Role of Metabolites in Nicotine Dependence (3) - 6
Tobacco Use Disorder
Principalinvestigator
NCT00000290Phase 1Completed
Stress Hormones and Human Cocaine Use - 7
Cocaine-Related Disorders
Principalinvestigator
NCT00000291Phase 2Completed
Effects of Labetalol on Human Cocaine Use - 8
Cocaine-Related Disorders
Principalinvestigator
NCT00000292Phase 1Completed
Acute Withdrawal From Smoked Cocaine - 9
Cocaine-Related DisordersSubstance Withdrawal SyndromeSubstance-Related Disorders
Principalinvestigator
NCT00000293Phase 3Completed
Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10
Cocaine-Related Disorders
Principalinvestigator

Showing 10 of 19 trials

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Cocaine-Related DisordersSubstance-Related DisordersTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score18%

Nancy A Rigotti, MD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Smoking CessationTobacco Use Disorder
Similarity Score12%

Elliot Stein, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
20 trials

Shared therapeutic areas:

Smoking CessationTobacco Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Jed E Rose, Ph.D.

Duke University

Related
11 trials

Shared therapeutic areas:

Smoking CessationSubstance Withdrawal Syndrome

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Related
10 trials

Shared therapeutic areas:

Cocaine-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score12%

John R Knight, MD

Boston Children's Hospital

Related
9 trials

Shared therapeutic areas:

Substance-Related DisordersTobacco Use Disorder
Similarity Score12%

Mark George, MD

Medical University of South Carolina

Related
6 trials

Shared therapeutic areas:

Smoking Cessation
Similarity Score6%

Madhukar Trivedi, MD

University of Texas Southwestern Medical Center

Related
13 trials

Shared therapeutic areas:

Smoking Cessation

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score6%

Tai hing Lam, MD

The University of Hong Kong

Related
10 trials

Shared therapeutic areas:

Smoking Cessation
Similarity Score6%

Sherry A McKee, PhD

Yale University

Related
10 trials

Shared therapeutic areas:

Smoking Cessation

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (19)

Showing 19 of 19 trials

NCT00000284Phase 2PrincipalInvestigator

Role of Metabolites in Nicotine Dependence (1) - 1

Tobacco Use Disorder
Completed
NCT00000285Phase 1PrincipalInvestigator

Effects of Phenytoin on Cocaine Use in Humans - 2

Cocaine-Related Disorders
Completed
NCT00000286Phase 2PrincipalInvestigator

Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3

Cocaine-Related Disorders
Completed
NCT00000287PrincipalInvestigator

Relapse Patterns in Female Cocaine Users - 4

Cocaine-Related Disorders
Completed
NCT00000288Phase 2PrincipalInvestigator

Role of Metabolites in Nicotine Dependence (2) - 5

Tobacco Use Disorder
Completed
NCT00000289Phase 2PrincipalInvestigator

Role of Metabolites in Nicotine Dependence (3) - 6

Tobacco Use Disorder
Completed
NCT00000290Phase 1PrincipalInvestigator

Stress Hormones and Human Cocaine Use - 7

Cocaine-Related Disorders
Completed
NCT00000291Phase 2PrincipalInvestigator

Effects of Labetalol on Human Cocaine Use - 8

Cocaine-Related Disorders
Completed
NCT00000292Phase 1PrincipalInvestigator

Acute Withdrawal From Smoked Cocaine - 9

Cocaine-Related DisordersSubstance Withdrawal SyndromeSubstance-Related Disorders
Completed
NCT00000293Phase 3PrincipalInvestigator

Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10

Cocaine-Related Disorders
Completed
NCT00000294Phase 2PrincipalInvestigator

Effects of Carvedilol on Cocaine Use in Humans - 11

Cocaine-Related Disorders
Completed
NCT00000295Phase 2PrincipalInvestigator

Progesterone Treatment in Female Smokers - 12

Tobacco Use Disorder
Completed
NCT00000296Phase 2PrincipalInvestigator

Role of Metabolites in Nicotine Dependence (4) - 13

Tobacco Use Disorder
Completed
NCT00000297Phase 2PrincipalInvestigator

Effects of Labetalol on Nicotine Administration in Humans - 14

Tobacco Use Disorder
Completed
NCT00158145PrincipalInvestigator

Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2

Tobacco Use Disorder
Completed
NCT00158158Phase 2/3PrincipalInvestigator

Effectiveness of Reducing Smoking in Facilitating Smoking Cessation in Adolescents - 2

Smoking CessationTobacco Use Disorder
Completed
NCT00158171Phase 2PrincipalInvestigator

Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1

Smoking CessationTobacco Use Disorder
Completed
NCT00710034Phase 2PrincipalInvestigator

Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine

Tobacco Use Disorder
Completed
NCT00711100Not ApplicablePrincipalInvestigator

Evaluation of Oral Tobacco as a Harm Reduction Method for Smokers

Tobacco Use Disorder
Completed

All 19 trials loaded